Sales decline 14.47% to Rs 128.54 crore
Net loss of Astrazeneca Pharma India reported to Rs 10.35 crore in the quarter ended December 2017 as against net profit of Rs 16.21 crore during the previous quarter ended December 2016.Sales declined 14.47% to Rs 128.54 crore in the quarter ended December 2017 as against Rs 150.29 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales128.54150.29 -14 OPM %-8.4310.06 -PBDT-8.0825.02 PL PBT-11.8121.00 PL NP-10.3516.21 PL
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)